The company closed its plan on October 27, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.59 CNY | -0.84% |
|
-3.46% | -14.80% |
Jun. 13 | China Approves Joincare's Anti-Asthma Drug | MT |
May. 28 | China Approves Joincare Unit's Asthma Drug | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.80% | 2.73B | |
+61.22% | 846B | |
+39.29% | 628B | |
-4.66% | 360B | |
+16.77% | 322B | |
+8.50% | 297B | |
+14.08% | 240B | |
+18.11% | 223B | |
+3.19% | 224B | |
+11.68% | 173B |
- Stock Market
- Equities
- 600380 Stock
- News Joincare Pharmaceutical Group Industry Co.,Ltd.
- Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback announced on December 15, 2022 has closed with 49,706,643 shares, representing 2.61% for CNY 599.91 million.